205 related articles for article (PubMed ID: 19087522)
1. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
[TBL] [Abstract][Full Text] [Related]
2. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
3. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
Liu YL; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
[TBL] [Abstract][Full Text] [Related]
4. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between cathepsin L and invasion and metastasis of ovarian carcinoma cells].
Wang SM; Li L; Zhang W; Li DR; Tang BJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):598-602. PubMed ID: 21029616
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
7. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.
Douma S; Van Laar T; Zevenhoven J; Meuwissen R; Van Garderen E; Peeper DS
Nature; 2004 Aug; 430(7003):1034-9. PubMed ID: 15329723
[TBL] [Abstract][Full Text] [Related]
8. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis.
Geiger TR; Peeper DS
Cancer Res; 2007 Jul; 67(13):6221-9. PubMed ID: 17616679
[TBL] [Abstract][Full Text] [Related]
9. [Effect of reduced expression of Her2 by RNA interference on the biological characters of ovarian carcinoma cells].
Wang KF; Cui H; Feng J; Yang R; Liang XD; Chang XH; Li Y; Cheng YX; Cheng HY; Ye X
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):622-5. PubMed ID: 19087501
[TBL] [Abstract][Full Text] [Related]
10. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
Li J; Liang SH; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
[TBL] [Abstract][Full Text] [Related]
11. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Zhao Y; Zong ZH; Xu HM
Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
[TBL] [Abstract][Full Text] [Related]
12. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
13. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.
Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD
J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effects of RNA interference on expression of matrix metalloproteinase-9 gene and invasiveness and adhesion in ovarian cancer cells].
Hu XX; Li L; Li DR; Zhang W; Tang BJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):579-83. PubMed ID: 17181964
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of invasive and chemotactic abilities of SKOV3 cells by human epithelial growth receptor-2 small interfering RNA].
Zhang SL; Lu YM; Meng LR; Zhao YY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):48-53. PubMed ID: 17331422
[TBL] [Abstract][Full Text] [Related]
16. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.
Au CW; Siu MK; Liao X; Wong ES; Ngan HY; Tam KF; Chan DC; Chan QK; Cheung AN
Cancer Lett; 2009 Aug; 281(2):151-61. PubMed ID: 19307055
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.
Sclabas GM; Fujioka S; Schmidt C; Li Z; Frederick WA; Yang W; Yokoi K; Evans DB; Abbruzzese JL; Hess KR; Zhang W; Fidler IJ; Chiao PJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):440-9. PubMed ID: 15701826
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
[TBL] [Abstract][Full Text] [Related]
20. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
